Huons acquires ‘generic’ approval of 0.9% Sodium Chloride Injection USP 5mL/10mL from U.S. FDA
Huons(CEO Gi-An Eom), a subsidiary of Huons Global, announced on the 24th that 0.9% Sodium Chloride Injection USP 5mL/10mL acquired a generic drug approval(ANDA) from the U.S. FDA.
Huons took a process of the ANDA(Abbreviated New Drug Application) for its 0.9% Sodium Chloride Injection USP 5mL/1...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
